Objective To investigate the effect of miRNA-384 ( miR-384) expression on hepatic steatosis in mice with nonalcoholic fatty liver disease ( NAFLD) induced by high-fat diet ( HFD) . Methods A total of 30 male C57 BL/6 J mice were fed for 7 days to adapt to the environment and then randomly divided into 2 groups, with 15 mice in each group. The mice in the control group were given normal diet, and those in the model group were given HFD for 8 weeks and then the liver tissue was harvested. HE and Nile red staining were used to observe the pathological changes of the liver. Microarray sequencing was performed to determine the whole-genome miRNA expression profile of liver tissue, and PCR was used to measure the relative expression of miR-384. The t-test was used for the comparison of continuous data between groups. Results In the control group, the liver was red with sharp edges, the lobular structure was clear, and there was no hepatic steatosis; in the model group, the liver was yellow with blunt edges, and the hepatocytes were swollen with a large number of fat vacuoles in the cytoplasm and nuclear deviation caused by the fusion of lipid droplets. Compared with the normal mice, the NAFLD mice had 12 upregulated miRNAs and 18 downregulated miRNAs in liver tissue. Some of the differentially expressed miRNAs between the control group and the model group were screened to obtain the same cluster diagram. Among the 8 miRNAs with significant changes, miR-384 showed a significant fold change. Conclusion The upregulation of miR-384 is closely associated with hepatic steatosis, but its mechanism still needs further study.
[1]CHENG Y, HOU T, PING J, et al.Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model[J].Proteome Science, 2016, 14 (1) :1-11.
|
[2]CHENG Y, GONG YH, ZHANG YH, et al.Effect of Jianpi Liqi Huatian Recipe Granule on FFA, HOMA-IR and APRI in patients with spleen deficiency and hypertrophic nonalcoholic steatohepatitis[J].Chin J Exp Med Formul, 2017, 23 (17) :200-204. (in Chinese) 成扬, 龚亚华, 张银华, 等.健脾理气化湿方配方颗粒治疗脾虚湿热型非酒精性脂肪性肝炎患者疗效及对FFA, HOMA-IR, APRI的影响[J].中国实验方剂学杂志, 2017, 23 (17) :200-204.
|
[3]HU ZJ, ZHANG J.China's non-alcoholic fatty liver disease research status[J].J Clin Hepatol, 2016, 32 (3) :552-556. (in Chinese) 胡中杰, 张晶.我国非酒精性脂肪性肝病的研究现状[J].临床肝胆病杂志, 2016, 32 (3) :552-556.
|
[4]AMBROS V.The functions of animal microRNAs[J].Nature, 2004, 431 (7006) :350-355.
|
[5]CHEN W, CHEN HH.MicroRNAs and liver diseases[J].J Commun Med, 2012, 10 (24) :40-42. (in Chinese) 陈汶, 陈宏辉.microRNAs与肝脏疾病[J].社区医学杂志, 2012, 10 (24) :40-42.
|
[6]TAKAHASHI K, YAN I, WEN HJ, et al.microRNAs in liver disease:from diagnostics to therapeutics[J].Clin Biochem, 2013, 46 (10) :946-952.
|
[7]PAN L, ZHANG JB, CUI RG, et al.Establishment of nonalcoholic fatty liver C57BL/6 mouse model[J].Chin J Tissue Engineer Res, 2016, 20 (40) :6054-6059. (in Chinese) 潘磊, 张金彪, 崔荣岗, 等.非酒精性脂肪肝C57BL/6小鼠模型的建立[J].中国组织工程研究, 2016, 20 (40) :6054-6059.
|
[8]ALY FZ, KLEINER D.Update on fatty liver disease and steatohepatitis[J].Adv Anat Pathol, 2011, 18 (4) :294-300.
|
[9]DAY CP, JAMES OF.Steatohepatitis:a tale of two"hits"?[J].Gastroenterology, 1998, 114 (4) :842-845.
|
[10]CHEN ZW, CHEN LY, DAI HL, et al.Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease[J].J Zhejiang Univ Sci B, 2008, 9 (8) :616-622.
|
[11]XIN SL, XU KS.Non-alcoholic fatty liver disease pathogenesis new understanding[J].J Clin Hepatol, 2017, 33 (8) :1581-1583. (in Chinese) 辛晟梁, 徐可树.非酒精性脂肪性肝病发病机制新认识[J].临床肝胆病杂志, 2017, 33 (8) :1581-1583.
|
[12] LIANG X.The relationship between microRNA-122 and the pathogenesis of fatty liver disease[D].Guangzhou:Guangzhou Med Coll, 2012. (in Chinese) 梁霞.微小RNA-122与脂肪性肝病发病关系的实验研究[D].广州:广州医学院, 2012.
|
[13]ZHANG Y, JIANG Y, QI FX.miRNA in chronic liver disease and its clinical significance[J].World Chin J Dig, 2014, 22 (28) :4257-4262. (in Chinese) 张颖, 江勇, 齐凤祥.miRNA在慢性肝病中的变化及其临床意义[J].世界华人消化杂志, 2014, 22 (28) :4257-4262.
|
[14]LI ZW, WU T, FU YX, et al.Expression and roles of MicroRNA-31 in HCC[J].Chin J Clin Pharmacol Ther, 2015, 20 (10) :1098-1101. (in Chinese) 李中文, 吴涛, 付应霄, 等.MicroRNA-31在肝癌中的表达和作用[J].中国临床药理学与治疗学, 2015, 20 (10) :1098-1101.
|
[15]FENG M, E CY, LI H, et al.Expression of miR-196a in liver cancer cells and its promotion effect on proliferation[J].J Jilin Univ:Med Edit, 2015, 41 (1) , 120-124. (in Chinese) 冯默, 鄂长勇, 李航, 等.miR-196a在肝癌细胞中的表达及其促增殖作用[J].吉林大学学报:医学版, 2015, 41 (1) :120-124.
|
[16]LI M, XIE HQ, XIONG W, et al.The role of MicroRNA in regulation of substance metabolism[J].J Central South Uni Med Edit, 2013, 38 (3) :318-322. (in Chinese) 李明, 谢慧清, 熊武, 等.MicroRNA在调控物质代谢方面的作用[J].中南大学学报医学版, 2013, 38 (3) :318-322.
|
[17]WANG YD, ZHAO CY.MicroRNA in liver disease research and application[J].Basic Clin Med, 2009, 29 (2) :216-219. (in Chinese) 王亚东, 赵彩彦.MicroRNA在肝病中的研究与应用[J].基础医学与临床, 2009, 29 (2) :216-219.
|
[18]LI S, XU YN, NIU X, et al.MiRNAs were used to screen differentially expressed miRNAs in the liver of different age pigs[J].China Anim Husb Veter Med, 2017, 44 (3) :673-678. (in Chinese) 李升, 许亚楠, 牛熙, 等.利用miRNA芯片筛选不同月龄香猪肝脏中差异表达的miRNA[J].中国畜牧兽医, 2017, 44 (3) :673-678.
|
[19]MA YH, XING HC.MicroRNA in liver fibrosis research progress[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (2) :1-4. (in Chinese) 马艳华, 邢卉春.microRNA在肝纤维化中的研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (2) :1-4.
|
[20]LI ZH.miRNA on molecular control of nonalcoholic fatty liver disease[D].Beijing:Beijing Univ Chem Technol, 2016. (in Chinese) 李泽浩.miRNA对非酒精性脂肪肝病变的分子调控作用[D].北京:北京化工大学, 2016.
|